Citron Research Covering Ambarella (AMBA) Short Sale

Citron Research said it is covering its Ambarella (NASDAQ: AMBA) short sale, saying it sees better opportunities elsewhere.

Citron first disclosed its Ambrella short publicly on June 19, with shares around $127. The current price is around $79, suggesting a gain on the short from Citron of around 38%.

Citron covering $AMBA short. Better opportunities elsewhere...has been a good one

— Citron Research (@CitronResearch) September 2, 2015

You May Also Be Interested In

• Regenxbio shares jump after FDA agrees to reverse drug rejection
• U.S. home prices rose 2.5% year over year in May, Redfin says
• South Korea leveraged ETF crisis sparks global chip selloff